No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6509074 |
chr19:43770566-43770567 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs144277636 |
chr19:43770591-43770592 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs535951961 |
chr19:43770593-43770594 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs147360212 |
chr19:43770598-43770599 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs577058901 |
chr19:43770607-43770608 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs545903487 |
chr19:43770610-43770611 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs377155289 |
chr19:43770616-43770617 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs559423994 |
chr19:43770631-43770632 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs528068382 |
chr19:43770637-43770638 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs542125671 |
chr19:43770658-43770659 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs201680409 |
chr19:43770669-43770670 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs561797636 |
chr19:43770696-43770697 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs199657535 |
chr19:43770705-43770706 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs192942566 |
chr19:43770737-43770738 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs550551216 |
chr19:43770770-43770771 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs535835121 |
chr19:43770780-43770781 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs185059253 |
chr19:43770788-43770789 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs533288542 |
chr19:43770800-43770801 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs546670131 |
chr19:43770812-43770813 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs566549331 |
chr19:43770821-43770822 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs10426441 |
chr19:43770842-43770843 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs556035857 |
chr19:43770863-43770864 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs62115908 |
chr19:43770868-43770869 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs150037800 |
chr19:43770885-43770886 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs190246982 |
chr19:43770888-43770889 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs113154291 |
chr19:43770923-43770924 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs374217671 |
chr19:43771007-43771008 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs117806098 |
chr19:43771044-43771045 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs145308580 |
chr19:43771052-43771053 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs559001570 |
chr19:43771067-43771068 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs553073156 |
chr19:43771074-43771075 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs572810265 |
chr19:43771114-43771115 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs371134245 |
chr19:43771171-43771172 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs181745885 |
chr19:43771177-43771178 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs184699431 |
chr19:43771186-43771187 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs577350415 |
chr19:43771199-43771200 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs544504779 |
chr19:43771241-43771242 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs530756075 |
chr19:43771244-43771245 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs375665285 |
chr19:43771248-43771249 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs35207205 |
chr19:43771274-43771275 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs189439509 |
chr19:43771280-43771281 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs546705064 |
chr19:43771282-43771283 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs34420375 |
chr19:43771284-43771285 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs115749421 |
chr19:43771349-43771350 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs529291916 |
chr19:43771356-43771357 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs12971301 |
chr19:43771382-43771383 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
47 |
rs180783268 |
chr19:43771383-43771384 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs538188965 |
chr19:43771387-43771388 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs542354647 |
chr19:43771388-43771389 |
Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs145042370 |
chr19:43771410-43771411 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|